By proceeding, you agree to our Terms of Use and Privacy Policy.
Isabel Aznarez is a co-founder and Vice President of Biology of Stoke Therapeutics. Isabel has extensive experience in human genetics, RNA metabolism, and modulation of RNA processes using antisense oligonucleotides.
Talks About #Research #medical
Preferred Locations #NorthAmerica
OPT Congress provides a unique opportunity to discuss advances in next-generation oligonucleotide therapies throughout the drug development process.
OPT Congress is now back in-person! OPT Congress provides a unique opportunity to discuss advances in next-generation oligonucleotide therapies throughout the drug development process.